Abstract: Air and surface chlorpyrifos residues were measured for 24 hours following a 0.5 percent Dursban@ broadcast application for fleas inside a residence. Two of the three treated rooms were ventilated following application. Maximum air concentrations were measured 3-7 hours post-application. Peak concentrations in the infant breathing zone were 94 Rg/m3 in the nonventilated room and 61 ,ug/m3 in the ventilated room, and were substantially higher than concentrations in the sitting adult breathing zone. Concentrations of approximately 30 ,ug/m3 were detected in the infant breathing zone 24 hours post-application. Surface residues available through wipe sampling were 0.7-1.6 ,ug/cm2 of carpet on the day of application and
Introduction
The health risks associated with residual pesticides in air and on surfaces in residences have only recently been examined from a public health perspective. The Committee on Urban Pest Management established by the US National Academy of Sciences noted that 5,000 health-related incidents involving pesticides were reported as occurring in homes in the US from 1966 to 1979.1 Home pesticide applications may pose health risks for occupants, particularly infants and children. A study of 20 adult residents exposed to dichlorvos following crack-and-crevice treatments found a slight decrease in group mean serum cholinesterase, with three residents reporting a feeling of illness 24 hours postapplication.2 Six of 21 children admitted to Arkansas Children's Hospital for organophosphate intoxication were judged to have been exposed following insecticide spraying inside the home.3 A review of 37 hospitalized pesticide poisonings among infants and children at the Children's Medical Center in Dallas, Texas revealed that five cases were due to pesticide absorption following spraying or fogging inside residences. 4 California State agencies reviewed 44 illness reports in 1984 associated with residential pesticide use,5 and subsequently conducted a hazard assessment for acute intoxication potential among infants following indoor pesticide treatments. 6 Concern also exists regarding the chronic health effects of children's exposure to pesticides. 7 Residential monitoring studies have focused primarily on ambient air concentrations of pesticides following several types of applications, including termiticide applications, [8] [9] [10] [11] [12] [13] DDVP resin strips hung in households,'4-6 and crackand-crevice or baseboard treatments. [17] [18] [19] [20] [21] [22] Recently the US Environmental Protection Agency initiated a major study of 0.3-0.5 F±g/cm2 24 hours post-application. Estimated total absorbed doses for infants were 0.08-0.16 mg/kg on the day of application and 0.04-0.06 mg/kg the day following application, with dermal absorption representing approximately 68 percent of the totals. These doses are 1.2-5.2 times the human No Observable Effect Level (NOEL). Exposures to cholinesterase inhibiting compounds following properly conducted broadcast applications could result in doses at or above the threshold of toxicological response in infants, and should be minimized through appropriate regulatory policy and public education. (Am J Public Health 1990; 80:689-693.) pesticide air concentrations in homes. 23 Limited studies of two additional application methods have been conducted. Broadcast applications,24,25 involve the hand spraying of an aqueous mixture directly onto target surfaces (e.g., rugs, floors, furniture), while total aerosol release applications (foggers)26-28 involve activation of a pressurized canister in an unoccupied room, with the pesticide aerosol covering all surfaces (walls, floor, ceiling). Both of these methods produce residues on surfaces to be contacted by occupants. Flea treatment by broadcast application was selected for study here because of the potential for both high air concentrations and substantial dermal exposure. A preliminary risk assessment has been conducted for crawling infants (9-10 months of age).
Methods
Sampling was conducted according to guidelines developed by the Canadian government's Department of Health and Air samples were collected in duplicate in each room prior to application and at the following time intervals post-application: 0-0.5 hours, 0.5-1, 1-1.5, 1.5-3, 3-5, 5-7. An additional two-hour sample was collected 24 hours post-application. The samplers were placed in the center of each room mounted 100 cm and 25 cm above the treated surface, approximately 1.5 m apart. Battery-powered porta-ble air sampling pumps with flow rates of 2 L/min were calibrated with the sampling train in line prior to and following the sampling period. Chlorpyrifos vapors were collected with ORBO-44 tubes (Supelpak 20) . Tubes were capped and stored in an ice chest for transport to the laboratory.
Aluminum foil squares (10 cm x 10 cm) were placed in the rooms before treatment to measure residues deposited on the carpet surface. Five squares were collected from each room immediately following application (5 minutes). The wipe procedure was based on the standard method of the US Occupational Safety and Health Administration.30 Sets of three wipes were collected in each room at eight time intervals post-application: 20, 40, 80, 100, 170, 260, 380 minutes, and 24 hours. All areas to be wiped were marked by disposable cardboard frames with 10 cm x 10 cm cut-out interiors. A new plastic glove was worn for each wipe sample to avoid cross-contamination of samples. The wipe consisted of three strokes across the surface with a 7.5 x 7.5 cm surgical gauze pad sprayed lightly with distilled water. This procedure was repeated with a second gauze pad, changing the wipe orientation 900. Pads were placed in glass storage jars in an ice chest for transport to the laboratory.
All samples were stored at -20°C until analysis. Granular contents of the Orbo-44 tubes were transferred into serum vials filled with 10.0 ml of pesticide-grade toluene. A subset of the samples were analyzed for breakthrough into the secondary section of the tubes, but such breakthrough was negligible. Capped vials were shaken at high speed (100 cpm) for 5 minutes on a mechanical shaking table, allowed to sit for 30 minutes and the extracts transferred to GC vials for analysis. Both the foil and the pads were extracted in 30 ml of toluene on the shaking table at high speed for 30 minutes and the extracts transferred into GC vials.
Samples were analyzed on a Hewlett Packard 5890A gas chromatograph equipped with an electron capture detector. Heptachlor epoxide was added to all samples as an internal standard. The limit of detection for i-,ul injections was 1 picogram/,l. The limits of detection for the sampling media were as follows: air samples, 83 ng/m3; foil and gauze samples, 0.6 ng/cm2. Solvent blanks run with each set of samples had no detectable chlorpyrifos. Fortification/ recovery studies were conducted for all sampling media. The mean and standard deviation from these studies were as follows: air samples, 85.3% ±6.0; aluminum foil squares, 98.6% ±2.5; gauze wipes, 84.0% ±10.1. Data have been adjusted on the basis of these recovery values. Two air samples, three foil and three wipe samples were collected in each room prior to application. No background chlorpyrifos levels were detected.
Results
Chlorpyrifos levels on aluminum foil samples collected immediately (5 minutes) following application averaged 13.6 ,ug/cm2 (+6.1) and levels in the three rooms were not significantly different. Measured deposition corresponded well with the 13 ,u.g/cm2 value calculated from label recommendations.
Chlorpyrifos residues available by wipe sampling in the ventilated rooms dropped by more than one-half within 30 minutes, averaging 0.7 p.g/cm2 throughout the remainder of Day 1 and 0.3 gu.g/cm2 24 hour post-application (Table 1) .
Surface residues in the nonventilated room followed the same pattern, but were significantly higher at all time intervals.
Chlorpyrifos vapors measured in the sitting adult breathing zone (100 cm above the carpet) increased over time (Figure 1 ). While concentrations in the ventilated rooms never exceeded 20 ,ug/m3, levels >60 ptg/m3 were measured in the nonventilated room 3-5 hours post-application. The effect of ventilation was further reflected in samples 24 hour post-application: >40 ,ug/m3 with no ventilation compared to <10 ,ug/m3 with ventilation.
Substantially higher chlorpyrifos concentrations were measured in the infant breathing zone (25 cm above carpet), with ventilation having far less impact ( Figure 2 neum of the infant is considered to be fully developed, the permeability of infant skin in humans has not been measured. 39 Studies in infant rats have demonstrated increased percutaneous absorption of chlorpyrifos relative to adults.40 Third, ingestion from deposits on hands would increase the estimates, since chlorpyrifos is absorbed by the oral route more efficiently than by the dermal route. 34 Finally, skin conditions to which infants may be particularly susceptible (e.g., dryness and rashes) are known to reduce the barrier properties of the skin. 39 The no observable effect level (NOEL) for chlorpyrifos is based on measurable changes in plasma acetylcholinesterase. The NOEL in humans is 0.03 mg/kg/day.4' All of the absorbed dose estimates in Table 2 exceed the NOEL, with doses 2.5-5 times the NOEL on Day 1, declining to 1.2-1.8 times on Day 2. The US Environmental Protection Agency has derived a "human reference dose" of0.003 mg/kg/day for chlorpyrifos by applying a 10-fold safety factor to the human NOEL. 42 The dose estimates in this study exceed the human reference dose by 10-50 times.
NOEL values are commonly employed to determine standards for human safety, but are based on an assumption of continuous exposure (e.g., Acceptable Daily Intakes of pesticide residues in foods). A similar assumption underlies the NAS guideline for indoor air concentrations.30 Since the potential exposures calculated here would be intermittent, their toxicological significance is difficult to interpret. As yet no short-term toxicological measure analogous to the NOEL is available.
Despite uncertainties in exposure/absorption estimates and toxicological interpretation, the dose values derived in this study raise a public health concern. Broadcast applications and possibly total release aerosol/fogging applications of acutely toxic insecticides may result in dermal and respiratory exposures sufficient to cause measurable toxicological responses in infants. While such exposures are not likely to produce recognizable symptoms of cholinesterase inhibition, the possibility of cases with subclinical effects cannot be ruled out. Confirmation of such exposures would require biological monitoring (e.g., detection of 3,5,6-trichloro-2-pyridinal in the urine for chlorpyrifos).
The potential for exposures greater than those reported here should also be noted. The training of many urban pesticide applicators is minimal and surveillance of application performance is nonexistent in most states. It is not unreasonable to assume that accidents and cases of inadvertent over-application will occur under these circumstances, albeit with low frequency. Furthermore, repeated applications for fleas and other household pests are not uncommon.
Current federal regulatory requirements for indoor pesticide applications are limited to label instructions. The label for broadcast applications of the compound under study here is typical (K. Lunchick, USEPA; personal communication); i.e., the premises should be vacated during application, and humans or pets should not contact treated surfaces until the spray has dried. These instructions are normally communicated by the applicator to occupants as a 1-2 hour reentry period. The finding of elevated air concentrations 3-7 hours post-application and the potential for dermal contact indicate that this reentry period is inappropriate for infants and small children. Several strategies are available to reduce the risks associated with indoor pesticide applications. First, notification requirements could be established to inform occupants of potential health risks and means for minimizing exposure. Recommendations for broadcast applications ofacutely toxic compounds such as chlorpyrifos might include thorough ventilation prior to reentry regardless of seasonal conditions, and well-defined reentry periods beyond 1-2 hours with special warnings regarding contact with treated surfaces by infants and small children. Second, more rigorous training and licensing procedures for applicators and application surveillance programs could be developed. Finally, product registrations could be modified or withdrawn for specific applications if an acceptable level of risk cannot be demonstrated. 
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